Clinical Trial

Safety and Efficacy of Remote Ischemic Conditioning for Patients Taking Off-pump Coronary Artery Bypass Grafting

Study acronym: IMPROVE
Recruiting
View on ClinicalTrials.gov →
Summary
Remote ischemic conditioning (RIC) is the process of repeated ischemia and reperfusion in the peripheral vessels, which is proved in reducing IRI in vital organs. This IMPROVE trial plans to enroll 648 patients who are diagnosed with coronary artery disease and are going to take off-pump CABG in five centers in China, to access whether RIC can and improve short-term prognosis.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-11-15; most recent amendment 2024-07-10.
Status change: Not Yet Recruiting → Recruiting 2024-07-10
Trial Details
NCT Number NCT06141525
Lead Sponsor First Affiliated Hospital Xi'an Jiaotong University
Collaborators: Beijing Anzhen Hospital, People's Hospital of Qinghai Province, The Second Hospital of Yulin City, Baoji Central Hospital
Conditions Coronary Artery Bypass Grafting, Remote Ischemic Conditioning, Ischemia-Reperfusion Injury
Enrollment 648 participants
Start Date 2023-11-22
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-03-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-12